A specialized medical device company developing and manufacturing advanced manipulation and collection equipment and ultrasound systems for breast cancer diagnosis and treatment.Aspecializedmedicaldevicecompanydevelopingandmanufacturingadvancedmanipulationandcollectionequipmentandultrasoundsystemsforbreastcancerdiagnosisandtreatment.
Key Products/TechnologiesKeyProducts/Technologies
Bexcore: A minimally invasive vacuum-assisted breast biopsy system for tissue collection and lesion removal. Features four-stage tissue resection size adjustment and safe biopsy for lesions located close to the skin. Includes a filter light for clear visibility in dark ultrasound examination rooms. An 8-inch display for checking and adjusting vacuum pressure and probe aperture settings. Continuous vacuum maintenance for reduced procedure time and efficient bleeding discharge. Key models include SYSTEM (BXS100) and PROBE (BXC W 145 - 8G*109mm, BXC W 140d - 10G*109mm)Bexcore:Aminimallyinvasivevacuum-assistedbreastbiopsysystemfortissuecollectionandlesionremoval.Featuresfour-stagetissueresectionsizeadjustmentandsafebiopsyforlesionslocatedclosetotheskin.Includesafilterlightforclearvisibilityindarkultrasoundexaminationrooms.An8-inchdisplayforcheckingandadjustingvacuumpressureandprobeaperturesettings.Continuousvacuummaintenanceforreducedproceduretimeandefficientbleedingdischarge.KeymodelsincludeSYSTEM(BXS100)andPROBE(BXCW145-8G*109mm,BXCW140d-10G*109mm)
Bexcore-i: A wireless rechargeable vacuum-assisted breast biopsy system, enhancing user convenience and reducing infection risk. Lighter and ergonomically designed compared to previous models. Obtained US FDA approvalBexcore-i:Awirelessrechargeablevacuum-assistedbreastbiopsysystem,enhancinguserconvenienceandreducinginfectionrisk.Lighterandergonomicallydesignedcomparedtopreviousmodels.ObtainedUSFDAapproval
Bexcore Expert: A next-generation vacuum-assisted breast biopsy device, integrating ultrasound-guided vacuum-assisted breast biopsy with stereotactic breast biopsy technology for microcalcification lesionsBexcoreExpert:Anext-generationvacuum-assistedbreastbiopsydevice,integratingultrasound-guidedvacuum-assistedbreastbiopsywithstereotacticbreastbiopsytechnologyformicrocalcificationlesions
MammouS (MammouS-N): A 3D Automatic Breast Ultrasound System (ABUS)MammouS(MammouS-N):A3DAutomaticBreastUltrasoundSystem(ABUS)
US-BOT: A next-generation robotic automatic ultrasound system, featuring 3D precise recognition of patient body shape via a high-performance camera. A robot arm autonomously finds the optimal scan path. Incorporates 'non-contact autonomous scan' technology to address compression pain issues of existing ABUSUS-BOT:Anext-generationroboticautomaticultrasoundsystem,featuring3Dpreciserecognitionofpatientbodyshapeviaahigh-performancecamera.Arobotarmautonomouslyfindstheoptimalscanpath.Incorporates'non-contactautonomousscan'technologytoaddresscompressionpainissuesofexistingABUS
Bexray: A breast specimen radiography deviceBexray:Abreastspecimenradiographydevice
Disealor: A handpiece-integrated ultrasonic surgical dissectorDisealor:Ahandpiece-integratedultrasonicsurgicaldissector
VACPEN: An electrosurgical knife that blocks smoke generated during surgery via vacuumVACPEN:Anelectrosurgicalknifethatblockssmokegeneratedduringsurgeryviavacuum
Intular: A disposable intubation laryngoscope with an integrated endoscope for smart device linkageIntular:Adisposableintubationlaryngoscopewithanintegratedendoscopeforsmartdevicelinkage
koABP: A reliable blood pressure monitor for hypertension patients, currently evolving into an ICT blood pressure monitor including SpO2 and ECGkoABP:Areliablebloodpressuremonitorforhypertensionpatients,currentlyevolvingintoanICTbloodpressuremonitorincludingSpO2andECG
Remusil Series: Markers used in breast diagnostic proceduresRemusilSeries:Markersusedinbreastdiagnosticprocedures
Core AdvantagesCoreAdvantages
Minimally Invasive Medical Device Technology: Expertise in developing the Bexcore system, reducing patient burden and accelerating recoveryMinimallyInvasiveMedicalDeviceTechnology:ExpertiseindevelopingtheBexcoresystem,reducingpatientburdenandacceleratingrecovery
Domestic Market Leadership: Bexcore holds the top position with approximately 45% market share in the Korean vacuum-assisted breast biopsy marketDomesticMarketLeadership:Bexcoreholdsthetoppositionwithapproximately45%marketshareintheKoreanvacuum-assistedbreastbiopsymarket
Global Certifications and Approvals: US FDA approval for Bexcore-i, CE, FDA, JPAL, ANVISA compliance for Bexcore, demonstrating international recognition of technology reliability and safetyGlobalCertificationsandApprovals:USFDAapprovalforBexcore-i,CE,FDA,JPAL,ANVISAcomplianceforBexcore,demonstratinginternationalrecognitionoftechnologyreliabilityandsafety
Continuous R&D and Innovation: Participation in various government R&D projects, including the Pan-Ministerial Medical Device R&D Project Group. Development of next-generation products like US-BOT with non-contact autonomous scan technology and Bexcore Expert with stereotactic breast biopsy capabilitiesContinuousR&DandInnovation:ParticipationinvariousgovernmentR&Dprojects,includingthePan-MinisterialMedicalDeviceR&DProjectGroup.Developmentofnext-generationproductslikeUS-BOTwithnon-contactautonomousscantechnologyandBexcoreExpertwithstereotacticbreastbiopsycapabilities
Strong Patent Portfolio: Possession of 17 patents, including those for 'Ultrasonic inspection device for deformable objects' in China, Europe, the US, and Japan, securing exclusive rights to core technologiesStrongPatentPortfolio:Possessionof17patents,includingthosefor'Ultrasonicinspectiondevicefordeformableobjects'inChina,Europe,theUS,andJapan,securingexclusiverightstocoretechnologies
Medical Field Expertise: The CEO's extensive clinical experience in breast cancer diagnosis and treatment, translating real-world medical needs into innovative product developmentMedicalFieldExpertise:TheCEO'sextensiveclinicalexperienceinbreastcancerdiagnosisandtreatment,translatingreal-worldmedicalneedsintoinnovativeproductdevelopment
Product Diversification: Provision of comprehensive medical solutions beyond vacuum-assisted breast biopsy systems, including automatic breast ultrasound, surgical equipment, and vital sign monitoring devicesProductDiversification:Provisionofcomprehensivemedicalsolutionsbeyondvacuum-assistedbreastbiopsysystems,includingautomaticbreastultrasound,surgicalequipment,andvitalsignmonitoringdevices
Export Competitiveness: Export of products to over 20 countries worldwide, including Italy, Poland, Vietnam, Iran, Europe, Southeast Asia, South America, Canada, Germany, Japan, Taiwan, and UAE, with over 10% annual export growth. Awarded the 'Million Dollar Export Tower' and Bexcore designated as a 'World-Class Product'ExportCompetitiveness:Exportofproductstoover20countriesworldwide,includingItaly,Poland,Vietnam,Iran,Europe,SoutheastAsia,SouthAmerica,Canada,Germany,Japan,Taiwan,andUAE,withover10%annualexportgrowth.Awardedthe'MillionDollarExportTower'andBexcoredesignatedasa'World-ClassProduct'
Target IndustriesTargetIndustries
Medical Device Manufacturing IndustryMedicalDeviceManufacturingIndustry
Healthcare Service IndustryHealthcareServiceIndustry
Patents: Holding 17 patents, including those for 'Ultrasonic inspection device for deformable objects' in China (ZL 2004 8 0001778.9), Europe (EP1587423B1), the US, and JapanPatents:Holding17patents,includingthosefor'Ultrasonicinspectiondevicefordeformableobjects'inChina(ZL200480001778.9),Europe(EP1587423B1),theUS,andJapan
Certifications: US FDA approval for Bexcore-i. CE, FDA, JPAL, ANVISA compliance for Bexcore. CE certification for Bexcore Fast biopsy needle (2020). KFDA certification for MammouS 3D Automatic Breast Ultrasound (2019). New Excellent Technology (NET) certification for Intular video flexible intubation laryngoscope (2016). ISO 9001 and ISO 13485 certifications (2015). Medical Device Manufacturing and Quality Management System (GMP) certification (2014). Venture Business certification (2013). US-BOT expected to receive KFDA medical device certification in the first half of 2026Certifications:USFDAapprovalforBexcore-i.CE,FDA,JPAL,ANVISAcomplianceforBexcore.CEcertificationforBexcoreFastbiopsyneedle(2020).KFDAcertificationforMammouS3DAutomaticBreastUltrasound(2019).NewExcellentTechnology(NET)certificationforIntularvideoflexibleintubationlaryngoscope(2016).ISO9001andISO13485certifications(2015).MedicalDeviceManufacturingandQualityManagementSystem(GMP)certification(2014).VentureBusinesscertification(2013).US-BOTexpectedtoreceiveKFDAmedicaldevicecertificationinthefirsthalfof2026
Awards: Medical Device Industry Association Chairman's Award for Meritorious Service (2020). Presidential Commendation (2019). Minister of Health and Welfare Award (2015). Gyeonggi Provincial Governor's Award for Social Contribution (2015). Gyeonggi Provincial Governor's Plaque of Appreciation (2013). Suwon Mayor's Commendation (2011). Ministry of Economy and Finance Commendation for Exemplary Taxpayer (2009). Awarded the 'Million Dollar Export Tower' (December 2024). Bexcore selected as a 'World-Class Product' (November 2021)Awards:MedicalDeviceIndustryAssociationChairman'sAwardforMeritoriousService(2020).PresidentialCommendation(2019).MinisterofHealthandWelfareAward(2015).GyeonggiProvincialGovernor'sAwardforSocialContribution(2015).GyeonggiProvincialGovernor'sPlaqueofAppreciation(2013).SuwonMayor'sCommendation(2011).MinistryofEconomyandFinanceCommendationforExemplaryTaxpayer(2009).Awardedthe'MillionDollarExportTower'(December2024).Bexcoreselectedasa'World-ClassProduct'(November2021)
Introduction
Location
767 Sinsu-ro, Suji-gu, Yongin-si, Gyeonggi-do, South Korea
클릭하여 위치 살펴보기
Information
767 Sinsu-ro, Suji-gu, Yongin-si, Gyeonggi-do, South Korea